MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jsps.2024.102029

Медицинская библиотека · Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024

The amelioration effect of antidiabetic agents on cytokine expression in patients with type 2 diabetes mellitus.

Abd El-Hameed Abeer M, Eskandrani Areej A, Salah Abdel-Reheim Eman, Abdel Moneim Adel, Addaleel Wessam

СтатьяПеревод в очереди

Аннотация

Inflammation is a condition that is closely linked to diabetes mellitus type 2 (T2DM), short for T2DM several different antidiabetic medications have been produced to regulate hyperglycemia, with indications that these therapies may have anti-inflammatory effects along with their glucose-lowering efficacy. Thus, this research was planned to explore the impact of antidiabetic agents on the cytokine expression levels -interleukin (IL)-1β, IL-6, IL-17, and IL-37 when patients have T2DM. In this study, 168 eligible subject matter was split into two groups: 50 healthy individuals and 118 cases with T2DM, who were classified into two subgroups: 30 untreated patients and 88 patients treated with metformin-based therapy. The outcome exhibited a significant increase within HbA1c% and proinflammatory cytokines (i.e., IL-1β, IL- 6, and IL-17), whereas IL-37 decreased considerably in untreated cases with T2DM compared to those in subjects who are healthy. Furthermore, the results showed increased levels Regarding waist size, body mass index and assessment using that homeostasis model, cholesterol, triglycerides, low-density lipoprotein levels, and heart danger elements in untreated cases with T2DM in comparison with hygienic subjects. Notably, treated patients with T2DM revealed an ameliorative impact on HbA1c, IL-6, IL-17, IL-37, IL-1β levels and lipid profile compared with untreated patients with T2DM. Antidiabetic agents may have a beneficial activity on the inflammatory status by reducing blood glucose levels, hyperlipidemia, and proinflammatory cytokines. The anti-inflammatory activity of IL-37 can apply a potentially effective therapeutic goal in treating T2DM and its complications.

Для цитирования: Abd El-Hameed Abeer M, Eskandrani Areej A, Salah Abdel-Reheim Eman, Abdel Moneim Adel, Addaleel Wessam. The amelioration effect of antidiabetic agents on cytokine expression in patients with type 2 diabetes mellitus.. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society. 2024. DOI: 10.1016/j.jsps.2024.102029.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.